IPG Investment Advisors LLC Invests $520,000 in Synopsys, Inc. $SNPS

IPG Investment Advisors LLC acquired a new stake in Synopsys, Inc. (NASDAQ:SNPSFree Report) during the fourth quarter, Holdings Channel reports. The institutional investor acquired 1,107 shares of the semiconductor company’s stock, valued at approximately $520,000.

A number of other institutional investors have also made changes to their positions in the business. Thurston Springer Miller Herd & Titak Inc. bought a new position in Synopsys in the fourth quarter valued at $28,000. Oakworth Capital Inc. increased its stake in Synopsys by 3,700.0% in the 4th quarter. Oakworth Capital Inc. now owns 76 shares of the semiconductor company’s stock valued at $36,000 after buying an additional 74 shares during the last quarter. KERR FINANCIAL PLANNING Corp bought a new stake in Synopsys during the 3rd quarter worth about $38,000. WealthCollab LLC lifted its position in Synopsys by 110.8% during the 3rd quarter. WealthCollab LLC now owns 78 shares of the semiconductor company’s stock worth $38,000 after buying an additional 41 shares in the last quarter. Finally, N.E.W. Advisory Services LLC boosted its stake in shares of Synopsys by 128.6% during the 4th quarter. N.E.W. Advisory Services LLC now owns 80 shares of the semiconductor company’s stock worth $38,000 after buying an additional 45 shares during the last quarter. Institutional investors own 85.47% of the company’s stock.

Synopsys Stock Down 8.6%

Shares of SNPS stock opened at $480.64 on Friday. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.26 and a current ratio of 1.36. The firm’s 50-day moving average is $458.59 and its 200-day moving average is $454.30. The stock has a market cap of $92.07 billion, a price-to-earnings ratio of 111.26, a PEG ratio of 4.31 and a beta of 1.25. Synopsys, Inc. has a 52-week low of $376.18 and a 52-week high of $651.73.

Synopsys (NASDAQ:SNPSGet Free Report) last posted its quarterly earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 EPS for the quarter, topping analysts’ consensus estimates of $3.15 by $0.20. The business had revenue of $2.28 billion during the quarter, compared to analysts’ expectations of $2.25 billion. Synopsys had a return on equity of 5.91% and a net margin of 8.91%.Synopsys’s quarterly revenue was up 41.9% on a year-over-year basis. During the same quarter last year, the company posted $3.67 earnings per share. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. Sell-side analysts predict that Synopsys, Inc. will post 10.28 EPS for the current year.

Analyst Ratings Changes

A number of research firms recently issued reports on SNPS. Stifel Nicolaus lifted their target price on Synopsys from $550.00 to $600.00 and gave the company a “buy” rating in a research report on Thursday. Citigroup increased their price target on Synopsys from $600.00 to $610.00 and gave the company a “buy” rating in a research report on Thursday. Bank of America raised their price target on Synopsys from $515.00 to $600.00 and gave the company a “buy” rating in a research note on Thursday. KeyCorp reaffirmed an “overweight” rating on shares of Synopsys in a research report on Thursday. Finally, Morgan Stanley upped their price objective on Synopsys from $480.00 to $525.00 and gave the stock an “equal weight” rating in a research note on Thursday. Nine investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, Synopsys presently has a consensus rating of “Hold” and an average target price of $563.81.

View Our Latest Report on SNPS

Synopsys News Summary

Here are the key news stories impacting Synopsys this week:

  • Positive Sentiment: Synopsys reported fiscal Q2 adjusted EPS of $3.35, beating estimates, on revenue of $2.28 billion, also ahead of expectations, with revenue up 41.9% year over year.
  • Positive Sentiment: The company lifted full-year FY2026 guidance, signaling continued demand for AI chip design software and stronger-than-expected momentum across the business.
  • Positive Sentiment: Synopsys reached a governance agreement with Elliott Investment Management and added Jesse Cohn to the board, which investors may view as a step toward better capital allocation and execution.
  • Positive Sentiment: Several analysts raised price targets after the earnings release, reflecting confidence in the company’s longer-term AI and semiconductor design opportunity.
  • Neutral Sentiment: Synopsys also showcased new AI-powered design flows and IP support for Samsung Foundry processes, reinforcing its position in advanced chip design.
  • Negative Sentiment: The stock is reacting negatively because investors may be worried that strong results are not enough to offset near-term business mix issues, including softness in chip IP and integration complexity tied to Ansys.

Synopsys Profile

(Free Report)

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

Read More

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPSFree Report).

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.